A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplant

Conditions:   Bronchiolitis Obliterans;   GVHD, Chronic;   Stem Cell Transplant Complications Interventions:   Drug: Liposomal Cyclosporine A;   Drug: Liposomal Placebo Sponsor:   Breath Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials